Schubert & CO Eli Lilly & CO Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $9,940 - $11,674	-32 Reduced 20.0%	128 $43,000
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $5,144 - $5,994	16 Added 11.11%	160 $58,000
Q3 2022 Oct 21, 2022	BUY	$296.48 - $337.87 $8,301 - $9,460	28 Added 24.14%	144 $47,000
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $17,281 - $20,290	62 Added 114.81%	116 $38,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $2,112 - $2,624	9 Added 20.0%	54 $15,000
Q4 2021 Jan 28, 2022	BUY	$224.85 - $279.04 $10,118 - $12,556	45 New	45 $12,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.